Performance

Monthly Listeners

Current

Followers

Current

Streams

Current

Tracks

Current

Global Rank

Current

Top Releases

View All

Soul of the Automaton

62K streams

62,044

Shape Shifter EP

51.6K streams

51,562

Vantage Point

50.3K streams

50,336

Asimov's Code

40.9K streams

40,875

Shape Shifter 2 EP

39.9K streams

39,935

Machine Life

37.5K streams

37,471

Distant Lands

35.3K streams

35,263

Manifold

33.1K streams

33,144

Night Time Activities

27.7K streams

27,737

Present Shock EP

26.5K streams

26,548

Biography

Electro leaning project by Conforce aka Boris Bunnik. Bookings: fran@sungaterecords.com The VersaLife corp is a multinational company active since the 1970s. It specializes in pharmaceuticals, bioengineering and nanotechnology. The VersaLife corp is a multinational company active since the 1970s. It specializes in pharmaceuticals, bioengineering and nanotechnology. VersaLife is a subsidiary of the firm Page Industries, whose owner is Bob Page. Its headquarters is located in Hong Kong, and has other major facilities such as in Roccasecca Beach, off the coast of San Francisco, USA. The company was founded in 1976 as Versatile Life Solutions. In 1993, one of VersaLife's subsidiaries, White Helix Labs, performed a series of experiments on newborn babies, likely as part of an early attempt to develop augmentation technology. Adam Jensen was the only survivor of this series of experiments, thought lost when his birth parents burnt down the labs. The years prior to 2000 were described as VersaLife's "golden age", until it went into a sharp decline. Despite this, however, in 2008 it was one of several major biotech companies to participate in biotech research at the controversial Omega Ranch. VersaLife was eventually delisted from the NYSE as it continued to fall in value. This all changed in 2016 when the failing pharmaceutical giant was purchased by the holding company, Page Industries. VersaLife did not start making a profit until it had been acquired by the larger conglomerate.